{"success":true,"data":{"pressRelease":{"id":"31121","rtpr_id":"nACS4kTYma","ticker":"CBDL","exchange":"OTC","all_tickers":["CBDL"],"title":"CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Flavored Vapes","author":"ACCESSWIRE","published_at":"2026-05-12T11:00:02.891Z","article_body":"The FDA Authorizes Fruit-Flavored Vapes for Adults 21 and Up Nationwide. CBD\nVapes Market size was valued at US$ 5.8 Billion in 2026, and is projected to\nreach US$ 20.9 Billion by 2033, growing at a CAGR of 20.5% from 2026 to 2033.\n\nSCOTTSDALE, AZ / ACCESS Newswire (https://www.accessnewswire.com/) / May 12,\n2026 / CBD Life Sciences Inc. (OTCID:CBDL) CBD Life Sciences Inc. is proud to\nannounce our latest product CBD Flavored Vapes that is Nicotine Free. Our CBD\nVape flavors are Menthol, Berry, Tropical and Mint. Vaping CBD allows for\nquick absorption into the bloodstream, leading to faster effects compared to\nother consumption methods like edibles or oils. Users often report feeling the\ncalming effects within minutes. The CBD Vapes will be available for purchase\nin the next two weeks.\n(https://app.accessnewswire.com/imagelibrary/936a9b45-3e01-4301-a776-81a2fab3e735/image.jpeg)\nLeadership Perspective: Positioning for Long-Term Growth\n\n\"CBD vapes are emerging as one of the most promising product opportunities in\nthe CBD supplement industry,\" said Lisa Nelson, President and Chief Executive\nOfficer of CBD Life Sciences Inc. \"As ongoing research continues to highlight\ntheir potential, we are taking decisive steps to position CBDL as a leader in\nthis growing market. Our commitment remains focused on expanding a strong CBD\nproduct ecosystem while creating lasting value for our shareholders.\"\n\nStrategic Alignment with a High-Growth Industry\n\nAs the CBD market continues to grow at a rapid pace, CBD vapes are becoming a\nmajor point of differentiation for innovative companies. Their\nnon-psychoactive properties, along with rising scientific interest and growing\nconsumer awareness, are fueling increased demand across both retail markets\nand research-focused sectors.\n\nCBDL believes its early entry and focused investment in CBD product\ndevelopment positions the Company to:\n*\nCapture first-mover advantage in an emerging CBD category\n*\nExpand market share across multiple product verticals\n*\nStrengthen brand authority in next-generation cannabinoid innovation\n*\nDrive long-term revenue growth and shareholder value\n\nAbout CBD Life Sciences Inc. (CBDL)\n\nCBD Life Sciences Inc. (OTC:CBDL) is a high-growth innovator in the\ncannabinoid and functional wellness sector, focused on developing and\ncommercializing premium CBD and next-generation cannabinoid products. With a\nrapidly expanding product portfolio and increasing presence across major\nretail and e-commerce platforms-including Walmart Marketplace-the Company is\nexecuting on a strategy designed to capture significant market share in a\nmulti-billion-dollar industry.Driven by innovation, strategic expansion, and a\ncommitment to quality, CBDL is actively positioning itself at the forefront of\nemerging cannabinoid trends, including CBG and other high-potential compounds.\nAs the Company continues to scale distribution and product offerings, it\nremains focused on accelerating revenue growth, strengthening brand\nrecognition, and maximizing long-term shareholder value.\n\nFollow our social media for the latest updates!\n\nX: https://www.x.com/CBDL_StockOTC\nInstagram: https://www.instagram.com/cbd.vault\nIR Contact: cbdvaultaz@gmail.com\nWebsite: https://www.thecbdvault.com\n\nForward-Looking Statements\n\nExcept for the historical information contained herein, the matters discussed\nin this press release are forward-looking statements. Actual results may\ndiffer materially from those described in forward-looking statements and are\nsubject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s\nfilings with OTC Markets, which may identify specific factors that may cause\nactual results or events to differ materially from those described in the\nforward-looking statements.\n\nSafe Harbor Statement\n\nThis release includes forward-looking statements, which are based on certain\nassumptions and reflect management's current expectations. These\nforward-looking statements are subject to a number of risks and uncertainties\nthat could cause actual results or events to differ materially from current\nexpectations. Some of these factors include general global economic\nconditions; general industry and market conditions, sector changes and growth\nrates; uncertainty as to whether our strategies and business plans will yield\nthe expected benefits; increasing competition; availability and cost of\ncapital; the ability to identify and develop and achieve commercial success;\nthe level of expenditures necessary to maintain and improve the quality of\nservices; changes in the economy; changes in laws and regulations, including\ncodes and standards, intellectual property rights, and tax matters; or other\nmatters not anticipated; our ability to secure and maintain strategic\nrelationships and distribution agreements. The Company disclaims any intention\nor obligation to update or revise any forward-looking ability to secure and\nmaintain strategic relationships and distribution agreements. The Company\ndisclaims any intention or obligation to update or revise any forward-looking\nstatements.\n\nContact Information\n\nLisa Nelson\nCEO\ncbdvaultaz@gmail.com\n(480) 209-1720\n\nSOURCE: CBD Life Sciences Inc.\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cbd-life-sciences-inc.-cbdl-announces-launch-of-cbd-flavored-vapes-1166042)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACS4kTYma","title":"CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Flavored Vapes","author":"ACCESSWIRE","ticker":"CBDL","created":"2026-05-12T11:00:02.891Z","tickers":["CBDL"],"exchange":"OTC","article_body":"The FDA Authorizes Fruit-Flavored Vapes for Adults 21 and Up Nationwide. CBD\nVapes Market size was valued at US$ 5.8 Billion in 2026, and is projected to\nreach US$ 20.9 Billion by 2033, growing at a CAGR of 20.5% from 2026 to 2033.\n\nSCOTTSDALE, AZ / ACCESS Newswire (https://www.accessnewswire.com/) / May 12,\n2026 / CBD Life Sciences Inc. (OTCID:CBDL) CBD Life Sciences Inc. is proud to\nannounce our latest product CBD Flavored Vapes that is Nicotine Free. Our CBD\nVape flavors are Menthol, Berry, Tropical and Mint. Vaping CBD allows for\nquick absorption into the bloodstream, leading to faster effects compared to\nother consumption methods like edibles or oils. Users often report feeling the\ncalming effects within minutes. The CBD Vapes will be available for purchase\nin the next two weeks.\n(https://app.accessnewswire.com/imagelibrary/936a9b45-3e01-4301-a776-81a2fab3e735/image.jpeg)\nLeadership Perspective: Positioning for Long-Term Growth\n\n\"CBD vapes are emerging as one of the most promising product opportunities in\nthe CBD supplement industry,\" said Lisa Nelson, President and Chief Executive\nOfficer of CBD Life Sciences Inc. \"As ongoing research continues to highlight\ntheir potential, we are taking decisive steps to position CBDL as a leader in\nthis growing market. Our commitment remains focused on expanding a strong CBD\nproduct ecosystem while creating lasting value for our shareholders.\"\n\nStrategic Alignment with a High-Growth Industry\n\nAs the CBD market continues to grow at a rapid pace, CBD vapes are becoming a\nmajor point of differentiation for innovative companies. Their\nnon-psychoactive properties, along with rising scientific interest and growing\nconsumer awareness, are fueling increased demand across both retail markets\nand research-focused sectors.\n\nCBDL believes its early entry and focused investment in CBD product\ndevelopment positions the Company to:\n*\nCapture first-mover advantage in an emerging CBD category\n*\nExpand market share across multiple product verticals\n*\nStrengthen brand authority in next-generation cannabinoid innovation\n*\nDrive long-term revenue growth and shareholder value\n\nAbout CBD Life Sciences Inc. (CBDL)\n\nCBD Life Sciences Inc. (OTC:CBDL) is a high-growth innovator in the\ncannabinoid and functional wellness sector, focused on developing and\ncommercializing premium CBD and next-generation cannabinoid products. With a\nrapidly expanding product portfolio and increasing presence across major\nretail and e-commerce platforms-including Walmart Marketplace-the Company is\nexecuting on a strategy designed to capture significant market share in a\nmulti-billion-dollar industry.Driven by innovation, strategic expansion, and a\ncommitment to quality, CBDL is actively positioning itself at the forefront of\nemerging cannabinoid trends, including CBG and other high-potential compounds.\nAs the Company continues to scale distribution and product offerings, it\nremains focused on accelerating revenue growth, strengthening brand\nrecognition, and maximizing long-term shareholder value.\n\nFollow our social media for the latest updates!\n\nX: https://www.x.com/CBDL_StockOTC\nInstagram: https://www.instagram.com/cbd.vault\nIR Contact: cbdvaultaz@gmail.com\nWebsite: https://www.thecbdvault.com\n\nForward-Looking Statements\n\nExcept for the historical information contained herein, the matters discussed\nin this press release are forward-looking statements. Actual results may\ndiffer materially from those described in forward-looking statements and are\nsubject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s\nfilings with OTC Markets, which may identify specific factors that may cause\nactual results or events to differ materially from those described in the\nforward-looking statements.\n\nSafe Harbor Statement\n\nThis release includes forward-looking statements, which are based on certain\nassumptions and reflect management's current expectations. These\nforward-looking statements are subject to a number of risks and uncertainties\nthat could cause actual results or events to differ materially from current\nexpectations. Some of these factors include general global economic\nconditions; general industry and market conditions, sector changes and growth\nrates; uncertainty as to whether our strategies and business plans will yield\nthe expected benefits; increasing competition; availability and cost of\ncapital; the ability to identify and develop and achieve commercial success;\nthe level of expenditures necessary to maintain and improve the quality of\nservices; changes in the economy; changes in laws and regulations, including\ncodes and standards, intellectual property rights, and tax matters; or other\nmatters not anticipated; our ability to secure and maintain strategic\nrelationships and distribution agreements. The Company disclaims any intention\nor obligation to update or revise any forward-looking ability to secure and\nmaintain strategic relationships and distribution agreements. The Company\ndisclaims any intention or obligation to update or revise any forward-looking\nstatements.\n\nContact Information\n\nLisa Nelson\nCEO\ncbdvaultaz@gmail.com\n(480) 209-1720\n\nSOURCE: CBD Life Sciences Inc.\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cbd-life-sciences-inc.-cbdl-announces-launch-of-cbd-flavored-vapes-1166042)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-05-12T11:00:02.913473702Z","server_sent_at_ms":1778583602913},"received_at":"2026-05-12T11:00:03.039Z","source_url":"https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cbd-life-sciences-inc.-cbdl-announces-launch-of-cbd-flavored-vapes-1166042"},"analysis":{"id":"22946","press_release_id":"31121","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"product_launch","narrative":"CBD Life Sciences Inc. (OTC:CBDL) announced the launch of its new CBD Flavored Vapes, which are nicotine-free and available in four flavors: Menthol, Berry, Tropical, and Mint.\n\nThe CBD Vapes market is projected to grow from US$ 5.8 billion in 2026 to US$ 20.9 billion by 2033, with a CAGR of 20.5%.\n\nCEO Lisa Nelson stated that CBD vapes are emerging as a promising product opportunity in the CBD supplement industry, positioning CBDL to capture first-mover advantage and expand market share.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"CBDL launches new CBD Flavored Vapes, positioning for growth in a rapidly expanding market."},"keyFigures":{"customDimensions":{"cagr_2026_2033":"20.5%","market_size_2026":"US$ 5.8 Billion","projected_market_size_2033":"US$ 20.9 Billion"}},"quotedText":"CBD vapes are emerging as one of the most promising product opportunities in the CBD supplement industry","namedEntities":{"people":[{"name":"Lisa Nelson","role":"President and CEO"}],"products":["CBD Flavored Vapes","Menthol","Berry","Tropical","Mint"],"companies":[{"name":"CBD Life Sciences Inc.","ticker":"CBDL"}],"dollarAmounts":[{"amount":"US$ 5.8 Billion","context":"CBD Vapes market size in 2026"},{"amount":"US$ 20.9 Billion","context":"projected CBD Vapes market size by 2033"}]},"materialImpact":{"score":3,"reasoning":"The launch of a new product line (CBD Flavored Vapes) in a rapidly growing market with a projected CAGR of 20.5% could position the company for increased market share and revenue growth."},"tickerRelevance":{"others":[],"primary":"CBDL"},"globalImportance":35,"audienceRelevance":50,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"OTC","eventGravity":"product_launch","sectorWeight":"Health Care","householdBrandBoost":"none","marketCapAdjustment":"small-cap","retailFavoriteBoost":"none"}},"event_type":"product_launch","event_type_secondary":null,"sentiment":"bullish","material_impact_score":3,"narrative":"CBD Life Sciences Inc. (OTC:CBDL) announced the launch of its new CBD Flavored Vapes, which are nicotine-free and available in four flavors: Menthol, Berry, Tropical, and Mint.\n\nThe CBD Vapes market is projected to grow from US$ 5.8 billion in 2026 to US$ 20.9 billion by 2033, with a CAGR of 20.5%.\n\nCEO Lisa Nelson stated that CBD vapes are emerging as a promising product opportunity in the CBD supplement industry, positioning CBDL to capture first-mover advantage and expand market share.","key_figures":{"customDimensions":{"cagr_2026_2033":"20.5%","market_size_2026":"US$ 5.8 Billion","projected_market_size_2033":"US$ 20.9 Billion"}},"named_entities":{"people":[{"name":"Lisa Nelson","role":"President and CEO"}],"products":["CBD Flavored Vapes","Menthol","Berry","Tropical","Mint"],"companies":[{"name":"CBD Life Sciences Inc.","ticker":"CBDL"}],"dollarAmounts":[{"amount":"US$ 5.8 Billion","context":"CBD Vapes market size in 2026"},{"amount":"US$ 20.9 Billion","context":"projected CBD Vapes market size by 2033"}]},"model_name":"Qwen/Qwen2.5-72B-Instruct-AWQ","prompt_hash":"sha256:a76fb3b19e8e8b7b","schema_hash":"sha256:8658c370b800cf3d","created_at":"2026-05-12T11:03:46.801Z","global_importance":35,"audience_relevance":50,"importance_components":{"tickerTier":"OTC","eventGravity":"product_launch","sectorWeight":"Health Care","householdBrandBoost":"none","marketCapAdjustment":"small-cap","retailFavoriteBoost":"none"}},"durationMs":12985,"modelName":"george-droid-qwen-72b"}}